Company Filing History:
1 out of 856 
1 out of 3,520 
Years Active: 2013
Title: Innovations of Hidewaki Nakagawa in Lung Cancer Diagnostics.
Introduction
Hidewaki Nakagawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical diagnostics, particularly in lung cancer detection. His innovative work has the potential to improve early diagnosis and treatment outcomes for patients.
Latest Patents
Nakagawa holds a patent for a lung cancer diagnostic polypeptide, which includes a method for detecting lung cancer and evaluating therapeutic effects. This novel biomarker is designed for use in lung cancer diagnosis, providing a crucial tool for healthcare professionals.
Career Highlights
Throughout his career, Nakagawa has worked with prominent organizations such as Riken Corporation and Shimadzu Corporation. His experience in these companies has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
He has collaborated with esteemed colleagues, including Koji Ueda and Atsuhiko Toyama, to advance research and development in lung cancer diagnostics.
Conclusion
Hidewaki Nakagawa's contributions to lung cancer diagnostics exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements in early detection and treatment of this critical disease.